MetLife Investment Management LLC Sells 1,258 Shares of Crocs, Inc. (NASDAQ:CROX)

MetLife Investment Management LLC reduced its position in Crocs, Inc. (NASDAQ:CROX) by 3.9% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 31,181 shares of the textile maker’s stock after selling 1,258 shares during the quarter. MetLife Investment Management LLC’s holdings in Crocs were worth $4,515,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. FMR LLC grew its holdings in Crocs by 4.8% during the 3rd quarter. FMR LLC now owns 8,907,591 shares of the textile maker’s stock worth $1,289,908,000 after acquiring an additional 406,287 shares during the period. Pacer Advisors Inc. boosted its position in shares of Crocs by 33.8% during the 3rd quarter. Pacer Advisors Inc. now owns 1,459,654 shares of the textile maker’s stock valued at $211,372,000 after purchasing an additional 368,557 shares in the last quarter. Thrivent Financial for Lutherans grew its stake in Crocs by 1.3% during the second quarter. Thrivent Financial for Lutherans now owns 901,973 shares of the textile maker’s stock worth $131,634,000 after purchasing an additional 11,986 shares during the period. Dimensional Fund Advisors LP increased its holdings in Crocs by 12.8% in the second quarter. Dimensional Fund Advisors LP now owns 790,225 shares of the textile maker’s stock worth $115,322,000 after purchasing an additional 89,610 shares in the last quarter. Finally, Van Lanschot Kempen Investment Management N.V. boosted its holdings in shares of Crocs by 6.7% during the 2nd quarter. Van Lanschot Kempen Investment Management N.V. now owns 521,726 shares of the textile maker’s stock worth $76,141,000 after buying an additional 32,984 shares in the last quarter. Institutional investors own 93.44% of the company’s stock.

Crocs Stock Performance

Shares of CROX stock opened at $105.60 on Monday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.90 and a current ratio of 1.43. The company has a market capitalization of $6.15 billion, a price-to-earnings ratio of 7.66, a PEG ratio of 1.07 and a beta of 2.01. Crocs, Inc. has a 52-week low of $85.71 and a 52-week high of $165.32. The company has a 50-day simple moving average of $121.89 and a two-hundred day simple moving average of $134.50.

Crocs (NASDAQ:CROX) last released its earnings results on Tuesday, October 29th. The textile maker reported $3.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.10 by $0.50. The company had revenue of $1.06 billion during the quarter, compared to analyst estimates of $1.05 billion. Crocs had a return on equity of 49.70% and a net margin of 20.50%. Crocs’s quarterly revenue was up 1.6% on a year-over-year basis. During the same period in the prior year, the company posted $3.25 earnings per share. Research analysts anticipate that Crocs, Inc. will post 12.93 EPS for the current fiscal year.

Insider Activity

In related news, Director John B. Replogle purchased 2,240 shares of Crocs stock in a transaction that occurred on Wednesday, October 30th. The stock was bought at an average price of $112.60 per share, for a total transaction of $252,224.00. Following the completion of the transaction, the director now owns 9,304 shares in the company, valued at $1,047,630.40. This represents a 31.71 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Susan L. Healy acquired 1,000 shares of the stock in a transaction on Wednesday, November 13th. The stock was bought at an average cost of $99.70 per share, for a total transaction of $99,700.00. Following the transaction, the chief financial officer now owns 22,652 shares of the company’s stock, valued at approximately $2,258,404.40. This trade represents a 4.62 % increase in their position. The disclosure for this purchase can be found here. Insiders own 2.72% of the company’s stock.

Wall Street Analysts Forecast Growth

CROX has been the subject of several research analyst reports. Monness Crespi & Hardt lowered their price objective on shares of Crocs from $170.00 to $140.00 and set a “buy” rating for the company in a research note on Wednesday, October 30th. Williams Trading raised shares of Crocs from a “hold” rating to a “buy” rating and increased their price objective for the stock from $135.00 to $163.00 in a research report on Thursday, August 22nd. KeyCorp reduced their target price on Crocs from $155.00 to $150.00 and set an “overweight” rating for the company in a research note on Wednesday, October 30th. Barclays cut their price target on Crocs from $164.00 to $125.00 and set an “overweight” rating on the stock in a report on Tuesday, October 29th. Finally, Loop Capital downgraded Crocs from a “buy” rating to a “hold” rating and decreased their price objective for the company from $150.00 to $110.00 in a report on Thursday, November 7th. Five equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $148.80.

Crocs Profile

Crocs, Inc, together with its subsidiaries, designs, develops, manufactures, markets, distributes, and sells casual lifestyle footwear and accessories for men, women, and children under Crocs and HEYDUDE Brand in the United States and internationally. The company offers various footwear products, including clogs, sandals, slides, flips, wedges, platforms, socks, boots, charms, flip flops, sneakers, and slippers.